Biological process
Response to lipid 11 8. Chronic myeloid leukemia 6 5.01x10 -13 AKT1, CCND1, CDKN2A, IKBKB, MAPK1, MAPK3 Pancreatic cancer 6 5.01x10 -13 AKT1, CCND1, CDKN2A, IKBKB, MAPK1, MAPK3 Non-small cell lung cancer 5 1.41x10 -10 AKT1, CCND1, CDKN2A, MAPK1, MAPK3 Acute myeloid leukemia 5 1.41x10 -10 AKT1, CCND1, IKBKB, MAPK1, MAPK3 Melanoma 5 1.41x10 -10 AKT1, CCND1, CDKN2A, MAPK1, MAPK3 Glioma 5 1.41x10 -10 AKT1, CCND1, CDKN2A, MAPK1, MAPK3 Prostate cancer 5 3.49x10 -10 AKT1, CCND1, IKBKB, MAPK1, MAPK3 Endocrine resistance 5 3.49x10 -10 AKT1, CCND1, CDKN2A, MAPK1, MAPK3 FoxO signaling pathway 5 1.25x10 -9 AKT1, CCND1, IKBKB, MAPK1, MAPK3 Hepatitis B 5 1.73x10 -9 AKT1, CCND1, IKBKB, MAPK1, MAPK3
